5Pellegrino R,Viegi G,Brusaseo V,et al.Interpretative strategies for lung function tests,gut Respir J,2005,26:948-968.
6Cocchiarella L,Anderson GB.Guides to the evaluation of permanent impairment.5th ed.Chicago:AMA Press,2000,8.
7Pellegrino R,Viegi G,Brusasco V,et al.Interpretative strategies for lung function tests.Eur Respir J,2005,26:948-968.
8Meneses AM,Perez-Padilla R,Jardim JR,et al.Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study):a prevalence study.Lancet,2005,26:1875-1881.
9Falaschetti E,Laiho J,Primatesta P,et al.Prediction equations for normal and low lung function from the Health Survey for England.Eur Respir J,2004,23:456-463.
4Global strategy for the diagnosis management and prevention of chr nic obstructive pulmonary disease ( COPD ) [ Internet ] [ updated 2006 ]. Available from : http ://www. goldcopd, org(2007-12-1 ).
5American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1995,152 :S77-S121.
6Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J, 1995,8 : 1398-1420.
7Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J,2005,26:948-968.
8Mannino DM,Sonia Buist A, Vollmer WM, et al. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax,2007,62:237-241.
9Roberts SD, Farber MO, Knox KS,et al. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest, 2006,130:200 -206.
10Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2007,176:532-555.
